Welcome to our dedicated page for Hcm Iv Acqsn SEC filings (Ticker: HACQU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on Hcm Iv Acqsn's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into Hcm Iv Acqsn's regulatory disclosures and financial reporting.
HCM IV Acquisition Corp. reported that, starting on April 6, 2026, investors who hold its Nasdaq-traded units (symbol “HACQU”) from the initial public offering may choose to trade the underlying Class A ordinary shares and warrants separately.
Each unit consists of one Class A ordinary share and one-quarter of one redeemable warrant, with each whole warrant exercisable to buy one Class A ordinary share at $11.50 per share. After separation, the Class A ordinary shares are expected to trade under “HACQ” and the warrants under “HACQW,” while any units that are not separated will continue trading under “HACQU.” No fractional warrants will be issued, and only whole warrants will trade.
HCM IV Acquisition Corp., a Cayman Islands-based SPAC, describes its structure and recent financing in its annual report. The company raised $287,500,000 by selling 28,750,000 units at $10.00 each in its IPO and placed the proceeds in a trust account. It also sold 4,666,667 private placement warrants for $7,000,000, and sponsor-related parties hold 8,625,000 founder shares bought for $25,000. As of March 19, 2026, about $288.2 million was held in the trust. HCM IV has not begun operating a business and will seek a merger or similar business combination, offering public shareholders redemption rights at roughly $10.05 per share if a deal is completed or if it liquidates after its allowed timeframe.
HCM IV Acquisition Corp. completed its initial public offering of 28,750,000 units at $10.00 per unit, including full exercise of the over‑allotment, for $287,500,000 of gross proceeds placed in a U.S. trust account. Each unit includes one Class A ordinary share and one‑quarter of a redeemable warrant exercisable at $11.50 per share. The SPAC is a blank check company with no operating business and has not selected or begun substantive talks with any acquisition target. Audited balance sheet data show Class A shares are fully redeemable at $10.00 per share, while the sponsor holds 8,625,000 Class B founder shares and 3,833,333 private placement warrants. The auditor’s report highlights substantial doubt about the company’s ability to continue as a going concern because it lacks sufficient cash and working capital outside the trust and must complete a business combination within 24 months or liquidate.
HCM IV Acquisition Corp., a blank check company, has completed its initial public offering of 28,750,000 units, including the full 3,750,000-unit over-allotment, at $10.00 per unit, for $287,500,000 in gross proceeds. Each unit includes one Class A ordinary share and one-third or one-fourth of a redeemable warrant, with each whole warrant exercisable at $11.50 per share.
The company also sold 4,666,667 private placement warrants to its sponsor and the underwriter at $1.50 per warrant, generating an additional $7,000,000. A total of $287,500,000, including $13,687,500 of deferred underwriting discount, has been placed in a U.S.-based trust account. These funds will remain in trust until a business combination is completed or the 24‑month deadline passes, when public shares may be redeemed.
The company’s amended and restated memorandum and articles of association were approved in connection with the IPO. HCM IV Acquisition Corp. plans to target businesses providing disruptive technology or innovations within the financial services industry.
HCM IV Acquisition Corp. director Michael J. Connor reported an “other” equity transaction involving 25,000 Class B ordinary shares. On February 11, 2026, the company’s sponsor, HCM Investor Holdings IV, LLC, assigned 25,000 Class B shares to Mr. Connor in connection with his appointment to the Board of Directors at a stated price of $0.003 per share.
The Class B ordinary shares are automatically convertible into Class A ordinary shares on a one-for-one basis at the time of the company’s initial business combination, subject to anti-dilution adjustments, and they have no expiration date. These Class B shares may be forfeited under certain circumstances related to Mr. Connor’s continued Board service.
HCM IV Acquisition Corp. director Thomas Albert Sapio reported an allocation of 25,000 Class B ordinary shares, assigned to him by the Sponsor under a securities purchase agreement in connection with his appointment to the board. These Class B shares are automatically convertible into Class A ordinary shares on a one-for-one basis at the time of the company’s initial business combination, subject to anti-dilution adjustments, and have no expiration date. The Class B shares are also subject to potential forfeiture under certain circumstances related to Mr. Sapio’s board service.
HCM IV Acquisition Corp. reported a Form 4 insider transaction reflecting an "other" change involving 75,000 Class B ordinary shares at $0.003 per share. After this transaction, 8,550,000 Class B ordinary shares were held indirectly.
Footnotes explain that in connection with the initial public offering and the appointments of Michael J. Connor, Richard Donohoe and Thomas Sapio to the Board of Directors, HCM IV Investor Holdings IV, LLC, the sponsor, assigned 25,000 Class B ordinary shares to each of these directors. The Class B ordinary shares are automatically convertible into Class A ordinary shares on a one-for-one basis at the time of the initial business combination, subject to anti-dilution adjustments, and have no expiration date.
The shares are held directly by the sponsor under a subscription agreement dated September 5, 2025. Shawn Matthews, the Chairman and Chief Executive Officer, is the managing member of the sponsor, has sole voting and dispositive control over the shares held by the sponsor, may be deemed the beneficial owner, and disclaims beneficial ownership of securities in which he has no pecuniary interest.
HCM IV Acquisition Corp. director Richard Charles Donohoe reported an "other" equity transaction involving 25,000 Class B ordinary shares on February 11, 2026. These shares were assigned to him by the Sponsor in connection with his appointment to the board at a stated price of $0.003 per share, leaving him with 25,000 shares directly held. The Class B ordinary shares are automatically convertible into Class A ordinary shares on a one-for-one basis upon the company’s initial business combination, subject to anti-dilution adjustments and potential forfeiture tied to his board service.